Literature DB >> 8381353

Chronic barbiturate treatment increases NMDA receptors but decreases kainate receptors in mouse cortex.

K R Short1, B Tabakoff.   

Abstract

Chronic phenobarbital effects on brain NMDA and kainate receptors were assessed using [3H]MK-801 and [3H]kainate. Mice fed a phenobarbital diet for 7 days had a higher density of MK-801 binding sites (NMDA receptors) but a lower density of kainate receptors in cortex than control mice. No changes in MK-801 or kainate binding were observed in hippocampus. The results suggest brain area specific adaptation of certain glutamate receptors to chronic barbiturate treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381353     DOI: 10.1016/0014-2999(93)90419-i

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Role of NMDA receptors in pentobarbital tolerance/dependence.

Authors:  S Oh; K Hoshi; I K Ho
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

2.  Down-regulation of synaptic GluN2B subunit-containing N-methyl-D-aspartate receptors: a physiological brake on CA1 neuron α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid hyperexcitability during benzodiazepine withdrawal.

Authors:  Guofu Shen; Elizabeth I Tietz
Journal:  J Pharmacol Exp Ther       Date:  2010-10-08       Impact factor: 4.030

3.  Effects of risperidone on glutamate receptor subtypes in developing rat brain.

Authors:  Yong Kee Choi; Matthew P Gardner; Frank I Tarazi
Journal:  Eur Neuropsychopharmacol       Date:  2008-10-09       Impact factor: 4.600

4.  Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence.

Authors:  M Rabbani; J Wright; A R Butterworth; Q Zhou; H J Little
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

5.  Changes in NMDAR2 subunit mRNA levels during pentobarbital tolerance/withdrawal in the rat brain: an in situ hybridization study.

Authors:  C G Jang; S Oh; I K Ho
Journal:  Neurochem Res       Date:  1998-11       Impact factor: 3.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.